Loading...
DOCS logo

Doximity, Inc.NYSE:DOCS Stock Report

Market Cap US$9.5b
Share Price
US$50.42
My Fair Value
n/a
1Y4.6%
7D1.6%
Portfolio Value
​
View

Doximity, Inc.

NYSE:DOCS Stock Report

Market Cap: US$9.5b

Doximity (DOCS) Stock Overview

Operates as a digital platform for medical professionals in the United States. More details

DOCS fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance6/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 4.6% below our estimate of its fair value

Earnings are forecast to grow 7.42% per year

Earnings grew by 45.3% over the past year

Analysts in good agreement that stock price will rise by 35.9%

Risk Analysis

No risks detected for DOCS from our risk checks.

DOCS Community Fair Values

Create Narrative

See what 70 others think this stock is worth. Follow their fair value or set your own to get alerts.

DOCS logo
Doximity

DOCS: Pharma Advertising Shift And AI Expansion Will Drive Measured Opportunity And Risks

Key Takeaways AI-powered workflow tools and high platform engagement drive deeper customer retention, higher revenue per user, and expanding long-term margins. Broad client demand and digital marketing trends position Doximity for sustained growth, improved sales efficiency, and earnings stability through diversified revenue streams.
View narrative
US$71.11
FV
29.1% undervalued intrinsic discount
10.98%
Revenue growth p.a.
0users have liked this narrative
1users have commented on this narrative
32users have followed this narrative
DOCS logo
Doximity

Digital Transformation And Telehealth Will Revolutionize Healthcare Collaboration

Key Takeaways Expansion of workflow modules and AI tools is driving platform growth, increasing user engagement, and bolstering high-margin SaaS opportunities. Strong industry tailwinds and leading clinician network position the company for sustained market share gains and recurring, higher-margin revenue streams.
View narrative
US$78.58
FV
35.8% undervalued intrinsic discount
12.52%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
DOCS logo
Doximity

Privacy Rules Will Squeeze Margins While Tools Will Support Recovery

Key Takeaways Rising compliance costs, platform fatigue, and stronger competition may compress margins and threaten Doximity's core revenue growth. Shifts in client digital marketing budgets and the move to integrated health IT platforms could increase customer churn and limit user expansion.
View narrative
US$50
FV
0.8% overvalued intrinsic discount
9.85%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
View Stock Community

Doximity, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Doximity
Historical stock prices
Current Share PriceUS$50.42
52 Week HighUS$85.21
52 Week LowUS$46.04
Beta1.36
1 Month Change-24.57%
3 Month Change-24.07%
1 Year Change4.61%
3 Year Change59.30%
5 Year Changen/a
Change since IPO-4.87%

Recent News & Updates

Doximity, Inc. (NYSE:DOCS) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Nov 14
Doximity, Inc. (NYSE:DOCS) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Recent updates

Doximity, Inc. (NYSE:DOCS) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Nov 14
Doximity, Inc. (NYSE:DOCS) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Doximity: Valuation Is Too Expensive For My Liking

Sep 20

At US$67.94, Is Doximity, Inc. (NYSE:DOCS) Worth Looking At Closely?

Sep 02
At US$67.94, Is Doximity, Inc. (NYSE:DOCS) Worth Looking At Closely?

We Think Doximity's (NYSE:DOCS) Profit Is Only A Baseline For What They Can Achieve

Aug 15
We Think Doximity's (NYSE:DOCS) Profit Is Only A Baseline For What They Can Achieve

Getting In Cheap On Doximity, Inc. (NYSE:DOCS) Is Unlikely

Jul 08
Getting In Cheap On Doximity, Inc. (NYSE:DOCS) Is Unlikely

With EPS Growth And More, Doximity (NYSE:DOCS) Makes An Interesting Case

Jun 23
With EPS Growth And More, Doximity (NYSE:DOCS) Makes An Interesting Case

At US$52.56, Is Doximity, Inc. (NYSE:DOCS) Worth Looking At Closely?

May 17
At US$52.56, Is Doximity, Inc. (NYSE:DOCS) Worth Looking At Closely?

Calculating The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

May 01
Calculating The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Shareholders Are Optimistic That Doximity (NYSE:DOCS) Will Multiply In Value

Apr 04
Shareholders Are Optimistic That Doximity (NYSE:DOCS) Will Multiply In Value

What Doximity, Inc.'s (NYSE:DOCS) 28% Share Price Gain Is Not Telling You

Feb 23
What Doximity, Inc.'s (NYSE:DOCS) 28% Share Price Gain Is Not Telling You

Doximity Q3 Earnings: Outpacing Even Management's Expectations

Feb 10

When Should You Buy Doximity, Inc. (NYSE:DOCS)?

Jan 24
When Should You Buy Doximity, Inc. (NYSE:DOCS)?

Doximity: Upgraded To Buy Amid Promising Growth And Strong Execution

Jan 13

Here's Why We Think Doximity (NYSE:DOCS) Is Well Worth Watching

Jan 06
Here's Why We Think Doximity (NYSE:DOCS) Is Well Worth Watching

Doximity: Strong Fundamentals And Growth Potential Makes It Attractive

Dec 06

Doximity (NYSE:DOCS) Knows How To Allocate Capital

Dec 01
Doximity (NYSE:DOCS) Knows How To Allocate Capital

Doximity: Downgrade To Hold On Valuation Concerns

Oct 03
User avatar

Generative AI And Digital Health Innovations Fuel Robust Revenue Growth And Market Expansion

Accelerating adoption of new products and a client portal, alongside strategic positioning with top clients, suggests sustained revenue expansion.

Doximity Faces Slower Revenue Growth As R&D Costs May Rise

Jul 23

Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)

May 17

Shareholder Returns

DOCSUS Healthcare ServicesUS Market
7D1.6%-10.1%-2.0%
1Y4.6%0.9%9.4%

Return vs Industry: DOCS exceeded the US Healthcare Services industry which returned 1.8% over the past year.

Return vs Market: DOCS underperformed the US Market which returned 9.4% over the past year.

Price Volatility

Is DOCS's price volatile compared to industry and market?
DOCS volatility
DOCS Average Weekly Movement6.4%
Healthcare Services Industry Average Movement9.4%
Market Average Movement6.5%
10% most volatile stocks in US Market17.1%
10% least volatile stocks in US Market2.9%

Stable Share Price: DOCS has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: DOCS's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010830Jeff Tangneywww.doximity.com

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems.

Doximity, Inc. Fundamentals Summary

How do Doximity's earnings and revenue compare to its market cap?
DOCS fundamental statistics
Market capUS$9.49b
Earnings (TTM)US$253.03m
Revenue (TTM)US$621.33m
37.5x
P/E Ratio
15.3x
P/S Ratio

Is DOCS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DOCS income statement (TTM)
RevenueUS$621.33m
Cost of RevenueUS$60.87m
Gross ProfitUS$560.46m
Other ExpensesUS$307.43m
EarningsUS$253.03m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)1.34
Gross Margin90.20%
Net Profit Margin40.72%
Debt/Equity Ratio0%

How did DOCS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/23 08:03
End of Day Share Price 2025/11/21 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Doximity, Inc. is covered by 28 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vikram KesavabhotlaBaird
Nisala WeerasuriyaBerenberg
Sean DodgeBMO Capital Markets Equity Research